{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:46:16Z","timestamp":1761518776972,"version":"3.32.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1097\/01.pas.0000160442.23523.0a","type":"journal-article","created":{"date-parts":[[2005,6,14]],"date-time":"2005-06-14T08:00:44Z","timestamp":1118736044000},"page":"976-979","source":"Crossref","is-referenced-by-count":25,"title":["Pulmonary Sarcoidosis Induced by Interferon-\u03b1 Therapy"],"prefix":"10.1097","volume":"29","author":[{"given":"Kelly J","family":"Butnor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210130","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1002\/1097-0142(19870301)59:5<896::AID-CNCR2820590507>3.0.CO;2-4","article-title":"Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma.","volume":"59","author":"Abdi","year":"1987","journal-title":"Cancer"},{"key":"R2-18-20210130","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0046-8177(78)80053-7","article-title":"Aluminum induced pulmonary granulomatosis.","volume":"9","author":"Chen","year":"1978","journal-title":"Hum Pathol"},{"key":"R3-18-20210130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1378\/chest.105.3.939","article-title":"Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C.","volume":"105","author":"Chin","year":"1994","journal-title":"Chest"},{"issue":"suppl","key":"R4-18-20210130","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1183\/09031936.01.18s320056","article-title":"Sarcoidosis: clinical update.","volume":"32","author":"Costabel","year":"2001","journal-title":"Eur Respir J Suppl"},{"key":"R5-18-20210130","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.1985.3.5.654","article-title":"Phase II study of recombinant alpha-2 interferon in resistant multiple myeloma.","volume":"3","author":"Costanzi","year":"1985","journal-title":"J Clin Oncol"},{"key":"R6-18-20210130","first-page":"493","article-title":"Sarcoidlike lung granulomatosis induced by aluminum dusts.","volume":"135","author":"De Vuyst","year":"1987","journal-title":"Am Rev Respir Dis"},{"issue":"suppl 1","key":"R7-18-20210130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.510260720","article-title":"Side effects of alpha interferon in chronic hepatitis C.","volume":"26","author":"Dusheiko","year":"1997","journal-title":"Hepatology"},{"issue":"suppl 1","key":"R8-18-20210130","first-page":"3","article-title":"Paris, 26-27 February 1999: Consensus statement.","volume":"31","author":"EASL International Consensus Conference on Hepatitis","year":"1999","journal-title":"J Hepatol"},{"key":"R9-18-20210130","first-page":"279","article-title":"Pulmonary disorders associated with Sjogrens syndrome.","volume":"50","author":"Fairfax","year":"1981","journal-title":"Q J Med"},{"key":"R10-18-20210130","first-page":"263","article-title":"Treatment of renal cell carcinoma with alpha (human leukocyte) interferon and vinblastine in combination: a phase I-II trial.","volume":"69","author":"Figlin","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"R11-18-20210130","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-9343(86)90705-9","article-title":"Recombinant leukocyte A interferon therapy for advanced hairy cell leukemia: therapeutic and immunologic results.","volume":"80","author":"Foon","year":"1986","journal-title":"Am J Med"},{"key":"R12-18-20210130","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1056\/NEJM198411013111803","article-title":"Treatment of advanced non-Hodgkins lymphoma with recombinant leukocyte A interferon.","volume":"311","author":"Foon","year":"1984","journal-title":"N Engl J Med"},{"key":"R13-18-20210130","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/S0168-8278(98)80357-7","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.","volume":"28","author":"Hoffmann","year":"1998","journal-title":"J Hepatol"},{"key":"R14-18-20210130","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1183\/09031936.96.09020380","article-title":"Nongranulomatous interstitial lung disease in Crohns disease.","volume":"9","author":"Hotermans","year":"1996","journal-title":"Eur Respir J"},{"key":"R15-18-20210130","first-page":"569","article-title":"Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis.","volume":"129","author":"Hunninghake","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"R16-18-20210130","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1056\/NEJM198305053081806","article-title":"Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposis sarcoma.","volume":"308","author":"Krown","year":"1983","journal-title":"N Engl J Med"},{"key":"R17-18-20210130","first-page":"723","article-title":"Human leukocyte (alpha) interferon in metastatic malignant melanoma: the American Cancer Society phase II trial.","volume":"68","author":"Krown","year":"1984","journal-title":"Cancer Treat Rep"},{"key":"R18-18-20210130","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1111\/j.1572-0241.2002.05999.x","article-title":"Significant pulmonary toxicity associated with interferon and ribavirin therapy for hepatitis C.","volume":"97","author":"Kumar","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R19-18-20210130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s535-002-8133-3","article-title":"Reactivation of sarcoidosis during interferon therapy.","volume":"37","author":"Li","year":"2002","journal-title":"J Gastroenterol"},{"key":"R20-18-20210130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1080\/00365540310016024","article-title":"Sarcoidosis, chronic hepatitis C and interferon-alpha: two cases.","volume":"35","author":"Luchi","year":"2003","journal-title":"Scand J Infect Dis"},{"key":"R21-18-20210130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0168-8278(99)80085-3","article-title":"Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection.","volume":"30","author":"Luers","year":"1999","journal-title":"J Hepatol"},{"key":"R22-18-20210130","first-page":"774","article-title":"Sarcoidosis.","volume":"110","author":"Mitchell","year":"1974","journal-title":"Am Rev Respir Dis"},{"key":"R23-18-20210130","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2169\/internalmedicine.35.376","article-title":"Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C.","volume":"35","author":"Nakajima","year":"1996","journal-title":"Intern Med"},{"key":"R24-18-20210130","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1023\/A:1015843908536","article-title":"Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature.","volume":"47","author":"Nawras","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R25-18-20210130","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/00004836-200209000-00018","article-title":"Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C.","volume":"35","author":"Noguchi","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R26-18-20210130","first-page":"CS5","article-title":"Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C.","volume":"10","author":"Papaioannides","year":"2004","journal-title":"Med Sci Monit"},{"key":"R27-18-20210130","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2893.2002.00105.x","article-title":"Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.","volume":"9","author":"Perez-Alvarez","year":"2002","journal-title":"J Viral Hepat"},{"key":"R28-18-20210130","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2214\/ajr.177.1.1770199","article-title":"Sarcoidosis induced by interferon therapy.","volume":"177","author":"Ravenel","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"R29-18-20210130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00004728-200303000-00030","article-title":"Interferon-induced sarcoidosis.","volume":"27","author":"Rubinowitz","year":"2003","journal-title":"J Comput Assist Tomogr"},{"key":"R30-18-20210130","first-page":"58","article-title":"Pulmonary sarcoidosis during interferon therapy: a rare or underestimated event?","volume":"19","author":"Salvio","year":"2004","journal-title":"Ann Ital Med Int"},{"key":"R31-18-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1021759120428","article-title":"Sarcoidosis after use of interferon for chronic hepatitis C: report of a case and review of the literature.","volume":"48","author":"Tahan","year":"2003","journal-title":"Dig Dis Sci"},{"key":"R32-18-20210130","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1056\/NEJM198604243141701","article-title":"Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.","volume":"314","author":"Talpaz","year":"1986","journal-title":"N Engl J Med"},{"key":"R33-18-20210130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2169\/internalmedicine.35.19","article-title":"Sarcoidosis after interferon therapy for chronic active hepatitis C.","volume":"35","author":"Teragawa","year":"1996","journal-title":"Intern Med"},{"key":"R34-18-20210130","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000196654","article-title":"Pulmonary sarcoid-like granulomata in a patient treated for extrapulmonary Hodgkins disease.","volume":"64","author":"van den B, Fickers","year":"1997","journal-title":"Respiration (Herrlisheim)"},{"key":"R35-18-20210130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1378\/chest.117.1.294","article-title":"Sarcoidosis and IFN-alpha treatment.","volume":"117","author":"Vander Els","year":"2000","journal-title":"Chest"},{"key":"R36-18-20210130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ajh.2830470330","article-title":"Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia.","volume":"47","author":"Yufu","year":"1994","journal-title":"Am J Hematol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.pas.0000160442.23523.0a","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T17:56:55Z","timestamp":1735754215000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-200507000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.pas.0000160442.23523.0a","relation":{},"ISSN":["0147-5185"],"issn-type":[{"type":"print","value":"0147-5185"}],"subject":[],"published":{"date-parts":[[2005,7]]}}}